We conducted a large-scale multicenter retrospective cohort study to verify whether preoperative CA19-9 is an independent prognostic factor in stage II-III CRC patients and further whether the prognostic impact of CA19-9 is dependent on CEA status. The gene discussed is CEACAM5; the disease is colorectal carcinoma.